Key takeaways

US healthcare venture fundraising set a record in 2019, reaching $10.7B, a 10% increase over the previous year.


Biopharma exits and returns nearly equaled 2018’s record year

Of the 50 venture-backed public offerings in 2019, 20 reached $1B+ market cap at year-end.


Dx/Tools realized most of its value in the public market

Two companies went public at a $2B+ valuation and positive post-IPO gains for the IPO class of 2019.


HealthTech IPOs emerged from a two-year drought

Four of the eight IPOs ended the year at $1B+ valuations.